In tauopathies, the aggregation of tau pathology has been suggested to follow disease‐specific spatio‐temporal spreading patterns1, 2 and to causally drive neurodegeneration and therefore symptom progression.3, 4. The gene discussed is MAPT; the disease is tauopathy.